Litcius/Paper detail

Cardiotoxicity in cancer patients treated with chemotherapy: A systematic review.

Maria Adriely Cunha Lima, Henrique Rodrigues de Almeida Brito, Gabriel Guimarães Mitidieri, Eduardo Paulo de Souza, Ana Caroline Gois Sobral, Hemmely Hevelyn Maria Araújo Melo, Guilherme Barreto Vasconcelos, Berila Beatriz Dias de Almeida, Thainá de Araújo Diniz Figueiredo, Marcello Augusto Anchieta Santos Filho, Douglas Silva Rosendo Santos, Renan Fontes de Carvalho, Halley Ferraro Oliveira

2022PubMed18 citationsOpen Access PDF

Abstract

Objective: The objective of the study was to assess the incidence of chemotherapy cardiotoxicity. Methods: This is a systematic review carried out through the PubMed, VHL and Scientific Electronic Library Online databases, using the descriptors "Cardiotoxicity" and "Chemotherapy" associated with the Boolean operator "AND." Initially, 15,090 articles were found between 2015 and 2021. After applying the defined inclusion and exclusion criteria, 80 studies remained, of which 27 underwent complete reading, after which all were included in the study. Results: = 89). Conclusion: Post-chemotherapeutic cardiotoxicity was mentioned in most studies, being present in a relevant percentage of the sample. Furthermore, these patients may develop other cardiovascular events.

Topics & Concepts

CardiotoxicityMedicineInternal medicineChemotherapyCancerTrastuzumabCardiomyopathyOncologyAnthracyclineAcute coronary syndromeInclusion and exclusion criteriaCardiologyBreast cancerHeart failureMyocardial infarctionPathologyAlternative medicineChemotherapy-induced cardiotoxicity and mitigationCancer-related cognitive impairment studiesChemotherapy-related skin toxicity